Viewing Study NCT05882058


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2026-05-27 @ 7:01 AM
Study NCT ID: NCT05882058
Status: RECRUITING
Last Update Posted: 2025-12-08
First Post: 2023-05-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Sponsor: Boehringer Ingelheim
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Lung Carcinoma View
None Neuroendocrine Neoplasms View
None Extra-pulmonary Neuroendocrine Carcinoma View
Keywords: